The objective of this 28-day study was to evaluate the ocular hypotensive efficacy and safety of AR-13324 ophthalmic solution compared with a positive control , latanoprost ophthalmic solution , in patients with open-angle glaucoma ( OAG ) or ocular hypertension ( OHT ) .